Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Chief Counsel Is Assistant Attorney General Bradshaw

This article was originally published in The Pink Sheet Daily

Executive Summary

Bradshaw brings extensive high-level government service experience to the position as he permanently replaces former Chief Counsel Troy. Deputy Chief Counsel Masoudi has served in the position on an interim basis since Troy’s departure in November.

Former Justice Department Principal Deputy Assistant Attorney General of the Civil Rights Division Sheldon Bradshaw was appointed FDA chief counsel April 1.

Bradshaw is the permanent replacement of former Chief Counsel Daniel Troy. Gerald Masoudi has served in the role on an interim basis since Troy's Nov. 24 departure (1 (Also see "FDA Acting Chief Counsel To Be Masoudi" - Pink Sheet, 16 Nov, 2004.)).

Bradshaw brings to the agency an extensive background in high-level government service.

Prior to his experience in the civil rights division, Bradshaw served as Deputy Assistant Attorney General in the Justice Department's Office of Legal Counsel.

Prior to joining DOJ, Bradshaw practiced law in the D.C. office of Howrey Simon Arnold & White. He previously served as law clerk to Judge Karen Williams, U.S. Court of Appeals for the Fourth Circuit.

Bradshaw is a graduate of Brigham Young University and the George Washington School of Law.

Masoudi, who joined the agency in November as deputy chief counsel, will return to the position (2 (Also see "Deputy Chief Counsel Masoudi Brings Antitrust Law Background To FDA" - Pink Sheet, 9 Nov, 2004.)).

Bradshaw officially joins FDA April 18.

- Andrew Shelton

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062126

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel